GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanopharmaceutics Inc (OTCPK:TGRP) » Definitions » Machinery, Furniture, Equipment

Nanopharmaceutics (Nanopharmaceutics) Machinery, Furniture, Equipment : $0.00 Mil (As of Sep. 2018)


View and export this data going back to 2016. Start your Free Trial

What is Nanopharmaceutics Machinery, Furniture, Equipment?

Nanopharmaceutics's Machinery, Furniture, Equipment for the quarter that ended in Sep. 2018 was $0.00 Mil.

Nanopharmaceutics's annual Machinery, Furniture, Equipment stayed the same from Dec. 2015 ($0.00 Mil) to Dec. 2016 ($0.00 Mil) but then increased from Dec. 2016 ($0.00 Mil) to Dec. 2017 ($1.04 Mil).


Nanopharmaceutics Machinery, Furniture, Equipment Historical Data

The historical data trend for Nanopharmaceutics's Machinery, Furniture, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanopharmaceutics Machinery, Furniture, Equipment Chart

Nanopharmaceutics Annual Data
Trend Dec15 Dec16 Dec17
Machinery, Furniture, Equipment
- - 1.04

Nanopharmaceutics Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
Machinery, Furniture, Equipment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - 1.04 - - -

Nanopharmaceutics Machinery, Furniture, Equipment Calculation

Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.


Nanopharmaceutics (Nanopharmaceutics) Business Description

Traded in Other Exchanges
N/A
Address
14120 NW 126 Terrace, Alachua, FL, USA, 32615
Nanopharmaceutics Inc is a clinical-stage specialty pharmaceutical company. It is engaged in developing oral, topical, and injectable products for cancer, central nervous system (CNS) disorders, and infectious diseases. The company's pipeline products include Triapine, Ammonium Tetrathiomolybdate, and Aza-TdC targeting cancer; NanoBUP, PRX-3140, NP-18-2, and NP-18-3 targeting CNS; and Ramoplanin and NanoDOX.